NCT02697305

Brief Summary

Branched chain amino acids (BCAA) are known to exert insulinogenic effect. Whether this effect is mediated by incretins (GLP-1, GIP) is not known. The aim of the study was to show incretin effect of BCAA, i.e. whether the oral administration of BCAA elicits higher insulin and incretin response when compared with IV route of the same dose of BCAA. Eighteen healthy, male subjects participated in three tests: IV application of BCAA solution (30.7±1.1 g of BCAA, IV BCAA) second was oral ingestion of BCAA capsules in the same dose (ORAL BCAA) and third experiment was oral placebo (PLACEBO). Glucose, insulin, GLP-1, GIP, valine, leucine and isoleucine levels were measured at time interval for up to 4 h.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 3, 2016

Completed
Last Updated

March 8, 2016

Status Verified

March 1, 2016

Enrollment Period

8 months

First QC Date

February 27, 2016

Last Update Submit

March 7, 2016

Conditions

Keywords

Insulin responseIncretin effectGLP-1GIPValineLeucineIsoleucineBranched chain amino acids

Outcome Measures

Primary Outcomes (1)

  • Area under the plasma concentration versus time curve (AUC) of GLP-1 and GIP

    At time 0, 15, 30, 45, 60, 90, 120 min serum levels of GLP-1 and GIP in peripheral blood samples were detected using commercially available ELISA kits

    0-120 min after administration

Secondary Outcomes (3)

  • Area under the plasma concentration versus time curve (AUC) of BCAA

    0-240 min after administration

  • Area under the plasma concentration versus time curve (AUC) of insulin

    0-240 min after administration

  • Area under the plasma concentration versus time curve (AUC) of glucose

    0-240 min after administration

Study Arms (3)

IV BCAA test

EXPERIMENTAL

IV application of BCAA solution

Dietary Supplement: IV BCAA

ORAL BCAA test

EXPERIMENTAL

At once oral ingestion of BCAA capsules

Dietary Supplement: ORAL BCAA

ORAL PLACEBO test

PLACEBO COMPARATOR

At once oral ingestion of placebo capsules

Other: ORAL Placebo

Interventions

IV BCAADIETARY_SUPPLEMENT

in total dose of 0,4 g/kg in a 2 h intravenous infusion

Also known as: Nutramin VLI 3%, Fresenius Kabi, KGaA, Germany
IV BCAA test
ORAL BCAADIETARY_SUPPLEMENT

single dose of 0.4g/kg administered over 30s washed down with 500mL of tap water

Also known as: BCAA capsules, Reflex Nutrition, UK, Brighton
ORAL BCAA test

single dose of 0.4 g/kg administered over 30 s washed down with 500mL of tap water

Also known as: methylcellulose, University Hospital Inst. Pharmacy prepared
ORAL PLACEBO test

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy volunteers

You may not qualify if:

  • age under 18 years, obesity, any chronic disease related to energy metabolism (particularly diabetes, thyreopathy, hypertension, dyslipidemia, atherosclerosis etc.), any chronic medication, smoking and regular alcohol consumption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Research on Diabetes, Metabolism and Nutrition, 3rd Faculty of Medicine, Charles University in Prague

Prague, 100 34, Czechia

Location

Related Publications (28)

  • Berger S, Vongaraya N. Insulin response to ingested protein in diabetes. Diabetes. 1966 May;15(5):303-6. doi: 10.2337/diab.15.5.303. No abstract available.

    PMID: 5936455BACKGROUND
  • Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966 Sep;45(9):1487-502. doi: 10.1172/JCI105456. No abstract available.

    PMID: 5919350BACKGROUND
  • Gannon MC, Nuttall FQ. Amino acid ingestion and glucose metabolism--a review. IUBMB Life. 2010 Sep;62(9):660-8. doi: 10.1002/iub.375.

    PMID: 20882645BACKGROUND
  • Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr. 2004 Nov;80(5):1246-53. doi: 10.1093/ajcn/80.5.1246.

    PMID: 15531672BACKGROUND
  • Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 2005 Jul;82(1):69-75. doi: 10.1093/ajcn.82.1.69.

    PMID: 16002802BACKGROUND
  • Pal S, Ellis V. The acute effects of four protein meals on insulin, glucose, appetite and energy intake in lean men. Br J Nutr. 2010 Oct;104(8):1241-8. doi: 10.1017/S0007114510001911. Epub 2010 May 11.

    PMID: 20456814BACKGROUND
  • Layman DK. The role of leucine in weight loss diets and glucose homeostasis. J Nutr. 2003 Jan;133(1):261S-267S. doi: 10.1093/jn/133.1.261S.

    PMID: 12514305BACKGROUND
  • Calbet JA, MacLean DA. Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans. J Nutr. 2002 Aug;132(8):2174-82. doi: 10.1093/jn/132.8.2174.

    PMID: 12163658BACKGROUND
  • Nilsson M, Holst JJ, Bjorck IM. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr. 2007 Apr;85(4):996-1004. doi: 10.1093/ajcn/85.4.996.

    PMID: 17413098BACKGROUND
  • Wahren J, Felig P, Hagenfeldt L. Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest. 1976 Apr;57(4):987-99. doi: 10.1172/JCI108375.

    PMID: 947963BACKGROUND
  • Yang J, Chi Y, Burkhardt BR, Guan Y, Wolf BA. Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr Rev. 2010 May;68(5):270-9. doi: 10.1111/j.1753-4887.2010.00282.x.

    PMID: 20500788BACKGROUND
  • Raptis S, Dollinger HC, Schroder KE, Schleyer M, Rothenbuchner G, Pfeiffer EF. Differences in insulin, growth hormone and pancreatic enzyme secretion after intravenous and intraduodenal administration of mixed amino acids in man. N Engl J Med. 1973 Jun 7;288(23):1199-202. doi: 10.1056/NEJM197306072882302. No abstract available.

    PMID: 4700552BACKGROUND
  • ELRICK H, STIMMLER L, HLAD CJ Jr, ARAI Y. PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION. J Clin Endocrinol Metab. 1964 Oct;24:1076-82. doi: 10.1210/jcem-24-10-1076. No abstract available.

    PMID: 14228531BACKGROUND
  • Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab. 1986 Aug;63(2):492-8. doi: 10.1210/jcem-63-2-492.

    PMID: 3522621BACKGROUND
  • Gunnerud U, Holst JJ, Ostman E, Bjorck I. The glycemic, insulinemic and plasma amino acid responses to equi-carbohydrate milk meals, a pilot- study of bovine and human milk. Nutr J. 2012 Oct 12;11:83. doi: 10.1186/1475-2891-11-83.

    PMID: 23057765BACKGROUND
  • Salehi A, Gunnerud U, Muhammed SJ, Ostman E, Holst JJ, Bjorck I, Rorsman P. The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on beta-cells. Nutr Metab (Lond). 2012 May 30;9(1):48. doi: 10.1186/1743-7075-9-48.

    PMID: 22647249BACKGROUND
  • Chen Q, Reimer RA. Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition. 2009 Mar;25(3):340-9. doi: 10.1016/j.nut.2008.08.012. Epub 2008 Nov 26.

    PMID: 19036562BACKGROUND
  • Tuma P, Gojda J. Rapid determination of branched chain amino acids in human blood plasma by pressure-assisted capillary electrophoresis with contactless conductivity detection. Electrophoresis. 2015 Aug;36(16):1969-75. doi: 10.1002/elps.201400585. Epub 2015 Apr 8.

    PMID: 25639649BACKGROUND
  • Tuma P. Rapid determination of globin chains in red blood cells by capillary electrophoresis using INSTCoated fused-silica capillary. J Sep Sci. 2014 Apr;37(8):1026-32. doi: 10.1002/jssc.201400044. Epub 2014 Mar 13.

    PMID: 24677638BACKGROUND
  • Rocha DM, Faloona GR, Unger RH. Glucagon-stimulating activity of 20 amino acids in dogs. J Clin Invest. 1972 Sep;51(9):2346-51. doi: 10.1172/JCI107046.

    PMID: 4639019BACKGROUND
  • Pedroso JA, Zampieri TT, Donato J Jr. Reviewing the Effects of L-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose Homeostasis. Nutrients. 2015 May 22;7(5):3914-37. doi: 10.3390/nu7053914.

    PMID: 26007339BACKGROUND
  • Palmer JP, Benson JW, Walter RM, Ensinck JW. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest. 1976 Sep;58(3):565-70. doi: 10.1172/JCI108502.

    PMID: 783201BACKGROUND
  • Vahl TP, Drazen DL, Seeley RJ, D'Alessio DA, Woods SC. Meal-anticipatory glucagon-like peptide-1 secretion in rats. Endocrinology. 2010 Feb;151(2):569-75. doi: 10.1210/en.2009-1002. Epub 2009 Nov 13.

    PMID: 19915164BACKGROUND
  • Marina AS, Kutina AV, Shakhmatova EI, Balbotkina EV, Natochin YV. Stimulation of glucagon-like peptide-1 secretion by water loading in human. Dokl Biol Sci. 2014 Nov;459:323-5. doi: 10.1134/S0012496614060027. Epub 2015 Jan 6. No abstract available.

    PMID: 25560206BACKGROUND
  • Yang J, Wong RK, Park M, Wu J, Cook JR, York DA, Deng S, Markmann J, Naji A, Wolf BA, Gao Z. Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic beta-cells. Diabetes. 2006 Jan;55(1):193-201.

    PMID: 16380493BACKGROUND
  • van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care. 2003 Mar;26(3):625-30. doi: 10.2337/diacare.26.3.625.

    PMID: 12610012BACKGROUND
  • Solerte SB, Fioravanti M, Locatelli E, Bonacasa R, Zamboni M, Basso C, Mazzoleni A, Mansi V, Geroutis N, Gazzaruso C. Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus. Am J Cardiol. 2008 Jun 2;101(11A):82E-88E. doi: 10.1016/j.amjcard.2008.03.006.

    PMID: 18514633BACKGROUND
  • Gojda J, Strakova R, Plihalova A, Tuma P, Potockova J, Polak J, Andel M. Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids. Ann Nutr Metab. 2017;70(4):293-302. doi: 10.1159/000475604. Epub 2017 Jun 9.

MeSH Terms

Conditions

Glucose Metabolism Disorders

Interventions

Methylcellulose

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

CelluloseGlucansPolysaccharidesCarbohydrates

Study Officials

  • Michal Anděl, Prof., MD

    3rd Faculty of Medicine, Charles University in Prague

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 27, 2016

First Posted

March 3, 2016

Study Start

September 1, 2014

Primary Completion

May 1, 2015

Study Completion

December 1, 2015

Last Updated

March 8, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will share

Locations